Insomnia is defined as a repeated difficulty with sleep initiation, maintenance, duration and/or quality of sleep. This occurs despite adequate opportunity and time for sleep and results in daytime impairment. Mild (transient or short-term) insomnia is known to affect between 30-50% of the general population, whilst chronic insomnia has a prevalence of 9-15%. This disorder affects energy levels, memory, concentration and problem solving skills. In addition, it has been linked to learning disabilities in children. Sleeplessness not only affects the individual but also produces social stress, lowered employee productivity and higher number of accidents. Therefore it is vital that the cause and treatment of insomnia is adequately addressed.
Common Conditions:
NOTICE TO PATIENTS
WellLab practices in the usual practitioner-referral system for pathology laboratories. Patients are highly recommended to seek the supervision and guidance of a qualified healthcare practitioner for the interpretation of any lab results and associated information. WellLab can offer assistance in locating a suitable practitioner.
Analytes
Midnight Collection
Cortisol (12-2am)
Melatonin (12-2am)